Ipamorelin 5mg + Tesamorelin 5mg | Growth Hormone Signaling Research Blend 10mg | Mile High Peptides LLC

Research Areas of Interest

Ipamorelin and Tesamorelin are investigated in laboratory and preclinical research involving:

• Growth hormone-related signaling pathways
• Growth hormone secretagogue receptor activity
• Growth hormone-releasing hormone (GHRH) receptor signaling
• Metabolic signaling pathways
• Body-composition research models
• Cellular responses to growth hormone-related signaling
• Interactions between complementary GH-related signaling mechanisms

These areas represent subjects of laboratory and preclinical investigation
and do not indicate safety, effectiveness, therapeutic benefit, or
suitability for human use.

Description

The Ipamorelin 5mg + Tesamorelin 5mg Research Blend
combines equal quantities of Ipamorelin and Tesamorelin in a single
10mg lyophilized research preparation.

Ipamorelin is investigated in experimental research
involving growth hormone secretagogue receptor activity and associated
growth hormone-related signaling mechanisms.

Tesamorelin is investigated in laboratory and preclinical
research involving growth hormone-releasing hormone (GHRH) receptor
signaling and associated downstream molecular and metabolic pathways.

Combining the two compounds in a defined research preparation allows
investigators to examine interactions between distinct growth
hormone-related signaling mechanisms within appropriately designed
experimental models.

Blend Composition

• Ipamorelin: 5mg
• Tesamorelin: 5mg
• Total research material: 10mg
• Ratio: 1:1

Product Details

• Components: Ipamorelin + Tesamorelin
• Ipamorelin quantity: 5mg
• Tesamorelin quantity: 5mg
• Total compound: 10mg
• Format: Lyophilized powder
• Blend format: Single blended research preparation
• Intended use: Laboratory research only
• Application: Analytical and in-vitro research

Research Information

Ipamorelin is studied in experimental models involving growth hormone
secretagogue receptor signaling and mechanisms associated with
growth hormone-related molecular responses.

Tesamorelin is studied in experimental models involving GHRH receptor
signaling and associated downstream growth hormone-related pathways.

The combined preparation may be incorporated into appropriately
designed experimental models examining interactions between
secretagogue-mediated and GHRH receptor-mediated signaling pathways.

Research observations may vary depending on methodology, handling,
storage conditions, experimental environment, and study design.

Important Notice

• For laboratory research and educational purposes only
• Not for human consumption
• Not for human or veterinary use
• Not for medical, cosmetic, or therapeutic use
• Not intended to diagnose, treat, cure, or prevent any disease
• Research observations may vary based on methodology, handling, storage, environment, and experimental conditions
• Material supplied is not a finished consumer product

Mile High Peptides LLC supplies this material strictly for analytical
and in-vitro laboratory research applications by qualified research
professionals.